Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Lung involvement in collagen diseases].

J Meier-Sydow1

  • 1Klinikum der J. W. Goethe-Universität, Frankfurt/Main.

Pneumologie (Stuttgart, Germany)
|February 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chronic cough.

Thorax·2000
Same author

Hormonal modifications in patients admitted to an internal intensive care unit for acute hypoxaemic respiratory failure.

Respiratory medicine·1996
Same author

[Pathogenesis of idiopathic pulmonary fibrosis].

Immunitat und Infektion·1995
Same author

[Differential diagnostic significance of complex values of gas exchange during submaximal physical effort in patients with emphysema and pulmonary fibrosis].

Pneumologie (Stuttgart, Germany)·1995
Same author

Experimental acute hypoxia in healthy subjects: evaluation of systolic and diastolic function of the left ventricle at rest and during exercise using echocardiography.

European journal of applied physiology and occupational physiology·1995
Same author

In vivo assessment of pulmonary oxidant damage: the role of bronchoalveolar lavage.

Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace·1994
Same journal

Pneumologie (Stuttgart, Germany)·2026
Same journal

Aerosol therapy during noninvasive ventilation (NIV) and nasal high-flow therapy (HFT): current technology and consensus-based recommendations.

Pneumologie (Stuttgart, Germany)·2026
Same journal

[Correction: Pharmacotherapy for Tobacco Dependence: Implementation of the Current G-BA Resolution - Erratum: Information from Section E3 of the DGP regarding the G-BA Resolution].

Pneumologie (Stuttgart, Germany)·2026
Same journal

[Pharmacotherapy for Tobacco Dependence: Implementation of the Current G-BA Resolution - Information from Section E3 of the DGP regarding the G-BA Resolution].

Pneumologie (Stuttgart, Germany)·2026
Same journal

[Acute lung failure].

Pneumologie (Stuttgart, Germany)·2026
Same journal

[The internet as a source of information for patients with sarcoidosis].

Pneumologie (Stuttgart, Germany)·2026
See all related articles

Connective tissue diseases frequently cause lung issues, requiring careful evaluation. While diagnosis is straightforward, treatment for these pulmonary manifestations often yields suboptimal outcomes.

Area of Science:

  • Rheumatology
  • Pulmonology
  • Immunology

Context:

  • Connective tissue diseases (CTDs) are often linked with significant pulmonary complications.
  • Pulmonary involvement in CTDs necessitates inclusion in differential diagnostic workups for respiratory symptoms.

Purpose:

  • To discuss the spectrum and frequency of pulmonary manifestations in connective tissue diseases.
  • To differentiate between direct CTD-related lung disease and "silent" alveolitis, a negative prognostic indicator.
  • To review current diagnostic and therapeutic strategies for pulmonary involvement in CTDs.

Summary:

  • Pulmonary manifestations are common in connective tissue diseases and require thorough pneumological assessment.
  • Distinguishing between direct lung disease and clinically silent, granulocytic alveolitis is crucial for prognosis.

Related Experiment Videos

  • Diagnostic approaches are generally effective, but treatment outcomes for pulmonary complications remain challenging.

    • Impact:

    • Highlights the importance of integrating rheumatological and pulmonological care for patients with connective tissue diseases.
    • Underscores the need for improved therapeutic strategies to manage lung disease in CTDs.
    • Emphasizes the prognostic significance of identifying specific types of pulmonary involvement, such as granulocytic alveolitis.